H.R. 3676 (119th)Bill Overview

Executive Order 14293 Act of 2025

Health|Health
Cosponsors
Support
Republican
Introduced
Jun 3, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker,…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill would give the force of law to Executive Order 14293, titled "regulatory relief to promote domestic production of critical medicines." The text of the bill is short: it codifies the Executive Order so its provisions operate as statutory law.

Why people may split

Progressives emphasize protecting safety and labor standards.

Watch point

Relative to its intended legislative type, this bill is a concise single-purpose measure that declares Executive Order 14293 shall have the force and effect of law.

This bill would give the force of law to Executive Order 14293, titled "regulatory relief to promote domestic production of critical medicines." The text of the bill is short: it codifies the Executive Order so its provisions operate as statutory law.

Passage35/100

Low complexity but substantive regulatory implications and lack of detail make obtaining broad support and surviving Senate process uncertain.

CredibilityMisaligned

Relative to its intended legislative type, this bill is a concise single-purpose measure that declares Executive Order 14293 shall have the force and effect of law. It provides a clear, narrow mechanism but lacks substantive statutory detail on implementation, fiscal effects, integration with existing law, edge cases, and accountability.

Contention30/100

Progressives emphasize protecting safety and labor standards.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesMakes Executive Order provisions legally binding, requiring agency compliance.
  • Potential benefitMay encourage private investment in domestic pharmaceutical manufacturing and related construction jobs.
  • Potential benefitCould strengthen supply chain resilience by reducing reliance on foreign medicine suppliers.
Likely burdened
  • Potential burdenMay lower regulatory safeguards if 'relief' reduces testing, inspection, or approval standards.
  • Federal agenciesReduces agency discretion by converting executive directives into binding statutory requirements.
  • Potential burdenCould prompt litigation over the scope, interpretation, or constitutionality of codified directives.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize protecting safety and labor standards.
Progressive65%

Generally supportive of boosting domestic medicine production, but wary of unspecified "regulatory relief." Concerned about safety, access, labor, and environmental protections.

Wants guarantees that relief won’t roll back FDA standards or worker protections.

Split reaction
Centrist75%

Cautiously favorable: supports domestic production and supply-security goals but wants targeted, evidence-based regulatory relief.

Seeks oversight, measurable outcomes, and budgetary clarity before strong endorsement.

Leans supportive
Conservative85%

Likely supportive: favors regulatory relief and domestic manufacturing incentives to reduce dependence on foreign supply chains.

Views codification as stronger, lasting policy than an executive order.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

Low complexity but substantive regulatory implications and lack of detail make obtaining broad support and surviving Senate process uncertain.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Exact substantive provisions of Executive Order 14293
  • Absent CBO or cost estimate and fiscal impacts
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize protecting safety and labor standards.

Low complexity but substantive regulatory implications and lack of detail make obtaining broad support and surviving Senate process uncerta…

Unlocked analysis

Relative to its intended legislative type, this bill is a concise single-purpose measure that declares Executive Order 14293 shall have the force and effect of law. It provides a clear, narrow mechanism but lacks substa…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis